Replies to post #117580 on Biotech Values

[jq1234]

I think so. I think the perceived value by acquirer vs perceived valued by acquiree is much wider in biotech/pharma space today. Plus, in today's investment envrionment where more and more investors take short term view, shareholders are more receptive to buyout than board.